Rhinocort and Extrapyramidal disorder - a phase IV clinical study of FDA data

Summary:

Extrapyramidal disorder is reported as a side effect among people who take Rhinocort (budesonide), especially for people who are female, 60+ old, also take Singulair, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Extrapyramidal disorder when taking Rhinocort. It is created by eHealthMe based on reports of 6,990 people who have side effects when taking Rhinocort from the FDA, and is updated regularly.

What is Rhinocort?

Rhinocort has active ingredients of budesonide. It is often used in allergies. eHealthMe is studying from 7,139 Rhinocort users. Check the latest studies of Rhinocort.

What is Extrapyramidal disorder?

Extrapyramidal disorder (involuntary muscle spasms in the face and neck) is found to be associated with 813 drugs and 960 conditions by eHealthMe. Check the latest studies of Extrapyramidal disorder.

On Jul, 15, 2026

6,990 people reported to have side effects when taking Rhinocort.
Among them, 11 people (0.16%) have Extrapyramidal disorder.

Could Rhinocort cause Extrapyramidal disorder?

Among these 11 people:

What is the gender of people who have Extrapyramidal disorder when taking Rhinocort? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Extrapyramidal disorder when taking Rhinocort? *

What are other drugs people take besides Rhinocort? *

What are other side effects people have besides Extrapyramidal disorder? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 9 people, 81.82%
Movement - Uncontrolled Or Slow: 5 people, 45.45%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 45.45%
Emotional Disorder: 5 people, 45.45%
Stress And Anxiety: 5 people, 45.45%
High Blood Pressure: 4 people, 36.36%
Abnormal Behavior: 4 people, 36.36%
Akathisia (a movement disorder characterized by a feeling of inner restlessness): 3 people, 27.27%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 27.27%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 27.27%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 18.18%
Indigestion: 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Skin Ulcer: 1 person, 9.09%
Pneumonia: 1 person, 9.09%
Pain: 1 person, 9.09%
Oesophageal Hypomotility (low movement of oesophagus): 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Infection: 1 person, 9.09%
Impaired Gastric Emptying: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rhinocort and have Extrapyramidal disorder?

- Check whether Extrapyramidal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rhinocort:

Rhinocort (7,139 reports)

Browse all side effects of Rhinocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Extrapyramidal disorder:

Extrapyramidal disorder (813 drugs)

Browse all the conditions that are associated with Extrapyramidal disorder:

Extrapyramidal disorder (960 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Rhinocort) and Rhinocort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.